Teen tobacco use falls to 25-year low as fewer pick up e-cigarettes

Teen tobacco use falls to 25-year low as fewer pick up e-cigarettes


In this photo illustration, ZYN nicotine cases and pouches are seen on a table on January 29, 2024 in New York City. 

Michael M. Santiago | Getty Images

Tobacco product use among middle and high school students has dropped to a 25-year low, the Centers for Disease Control and Prevention and the U.S. Food and Drug Administration announced on Thursday.

The CDC and FDA recorded data on youth tobacco product use through the National Youth Tobacco Survey, which found that 2.25 million middle and high school students reported they had used any tobacco product in the last 30 days, down from 2.8 million in 2023.

The drop reflected a decline in students who said they were using electronic cigarettes, down to 1.63 million in 2024 from 2.13 million in 2023.

“We’re headed in the right direction when it comes to reducing tobacco product use among our nation’s youth,” Brian King, director of the FDA’s Center for Tobacco Products, said in a press release on Thursday. “But we can’t take our foot off the gas. Continued vigilance is needed to continue to reduce all forms of tobacco product use among youth. Addressing disparities remains an essential part of these efforts to ensure that we don’t leave anyone behind.”

Female students reported the biggest decline in use across the board, and Hispanic students also reported a drop in use of any tobacco product. Evidence-based strategies, including price increases, media campaigns and smoke-free policies, are likely part of what caused tobacco product use to drop, according to the agencies.

E-cigarettes continue to be the most used among students who reported tobacco product use, at 5.9%, but nicotine pouches are now the second most commonly used tobacco product, at 1.8%, followed by cigarettes at 1.4%.

Nicotine pouch use actually grew among students, though not enough to be considered significant, from 1.2% in 2023 to 1.8% in 2024, the CDC said in September.

“Youth use of tobacco products in any form — including e-cigarettes and nicotine pouches — is unsafe,” Deirdre Lawrence Kittner, the director of the CDC’s office on smoking and health, said in a press release in September. “It’s essential that we remain vigilant and committed to public health efforts to ensure all youth can live healthy, tobacco-free lives.”

Zyn was the most popular nicotine pouch brand, at 68.7%, compared with the next most popular brand On at 14.2%.

Zyn, the oral nicotine pouch brand owned by Philip Morris International, exploded in popularity on social media earlier this year which led to a nationwide shortage. Philip Morris in July announced plans to invest $600 million into a new Zyn production facility in Colorado in response to the spike in demand.

The survey was distributed among 29,861 students from 283 schools from Jan. 22 to May 22.



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More